Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Solid Biosciences Inc. Director's Dealing 2021

Feb 1, 2021

33003_dirs_2021-02-01_c535d63f-15e2-4ef1-9cf9-09297ffa3e7f.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Solid Biosciences Inc. (SLDB)
CIK: 0001707502
Period of Report: 2021-01-29

Reporting Person: DiPalma Stephen J. (Interim CFO)

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Warrant (right to buy) $3.29 2030-11-19 Common Stock (30000) Indirect

Footnotes

F1: The warrant was issued on November 20, 2020 and vests on a monthly basis over six months from the date of issuance.

F2: The warrant was issued to Danforth Advisors, LLC, of which the Reporting Person is a Managing Director, pursuant to a consulting agreement, dated November 19, 2020, between the Issuer and Danforth Advisors, LLC.